Shell Asset Management’s Arcturus Therapeutics ARCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,282	Closed	-$69K	–	1160
2025 Q2	$69K	Sell	5,282 -6,767	-56%	-$80K	﹤0.01%	1080
2025 Q1	$128K	Sell	12,049 -505	-4%	-$8.02K	0.01%	948
2024 Q4	$213K	Hold	12,554	–	–	0.01%	817
2024 Q3	$291K	Buy	+12,554	New	+$269K	0.01%	702
2024 Q1	$313K	Sell	12,869 -3,905	-23%	-$138K	0.01%	665
2023 Q4	$529K	Sell	16,774 -5,030	-23%	-$120K	0.02%	496
2023 Q3	$557K	Sell	21,804 -377	-2%	-$11.6K	0.02%	518
2023 Q2	$636K	Sell	22,181 -7,517	-25%	-$205K	0.03%	496
2023 Q1	$712K	Buy	29,698 +13,843	+87%	+$248K	0.03%	449
2022 Q4	$269K	Buy	+15,855	New	+$276K	0.01%	819
2020 Q4	–	Sell	-1,510	Closed	-$65K	–	1435
2020 Q3	$65K	Hold	1,510	–	–	﹤0.01%	1236
2020 Q2	$71K	Buy	+1,510	New	+$52K	﹤0.01%	1197